| Literature DB >> 26970957 |
Caroline S Kampshoff1, Fiona Stacey2, Camille E Short3, Willem van Mechelen1, Mai Jm Chinapaw1, Johannes Brug4, Ronald Plotnikoff5, Erica L James2, Laurien M Buffart6.
Abstract
PURPOSE: The aim of this study was to identify demographic, clinical, psychosocial, and environmental correlates of objectively assessed physical activity among breast cancer survivors.Entities:
Keywords: Accelerometers; Breast cancer; Correlates; Pedometers; Physical activity
Mesh:
Year: 2016 PMID: 26970957 PMCID: PMC4917571 DOI: 10.1007/s00520-016-3148-8
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Fig. 1Inclusion criteria, recruitment strategies, and differences between participants and non-participants of the included studies
Baseline characteristics
| REACT | ENRICH | MM4L | Pooled | |
|---|---|---|---|---|
|
| ||||
| Mean daily activity counts, mean (SD) | 252.3 (97.8) | }z-score | ||
| Mean daily steps, mean (SD) | 8406.2 (3485.5) | 7694.8 (2831.6) | ||
|
| ||||
| Age, mean (SD) (years) | 51.8 (9.4) | 54.8 (11.0) | 55.9 (8.3) | 54.5 (9.2) |
| Married or de facto ( | 148 (82) | 41 (64) | 250 (77) | 439 (77) |
| Education | ||||
| Low/intermediate ( | 106 (60) | 34 (54) | 184 (56) | 324 (57) |
| High ( | 72 (40) | 29 (46) | 146 (44) | 247 (43) |
| Being employed, | ||||
| Employed, ( | 121 (67) | 32 (51) | 189 (57) | 342 (60) |
| Not employed, ( | 59 (33) | 31 (49) | 141 (43) | 231 (40) |
|
| ||||
| Type of treatment, | ||||
| Chemotherapy (yes) ( | 180 (100) | 52 (85) | 231 (70) | 463 (81) |
| Radiation therapy (yes) ( | 124 (69) | 49 (85) | 225 (68) | 398 (70) |
| Surgery (yes) ( | 177 (98) | 62 (97) | 306 (93) | 545 (95) |
| Immunotherapy (yes) ( | 35 (19) | 0 | 15 (5) | 50 (9) |
| Hormone therapy (yes) ( | 125 (69) | 45 (82) | 201 (61) | 371 (66) |
| Time between date of diagnosis and baseline, mean (SD) (months) | 7.9 (1.5) | 44.2 (83.5) | 69.0 (50.9) | 47.6 (55.1) |
| History of cancer (yes) ( | 15 (8) | 4 (7) | 19 (6) | 38 (7) |
| Sum of comorbidities, mean (SD) | 0.5 (0.7) | 2.3 (1.7) | 1.7 (1.5) | 1.4 (1.5) |
| BMI (kg/m2), mean (SD) | 27.2 (4.8) | 27.0 (6.1) | 26.9 (5.2) | 27.0 (5.2) |
|
| ||||
| Self-efficacy, mean (SD) | 60.0 (16.7) | 52.5 (17.8) | 50.7 (22.3) | z-score |
| Social support, mean (SD) | 80.3 (20.4) | 48.8 (33.2) | 30.1 (15.6) | z-score |
| Outcome expectations, mean (SD) | 76.4 (14.7) | 73.4 (16.6) | 81.8 (13.9) | 79.2 (14.8) |
|
| ||||
| Urban area, (yes) ( | 45 (25) | 64 (100) | 155 (47) | 264 (46) |
SD standard deviation, n number
Unstandardized and standardized regression coefficients and their 95 % confidence intervals as results from univariable and multivariable regression analyses with PA z-scores as dependent variable and demographic, clinical, psychosocial, and environmental variables as independent variables
| Univariable | Multivariable | Multivariable | |
|---|---|---|---|
|
| |||
| Age (years) | −0.01 (−0.02; −0.01)* | −0.01 (−0.02; −0.003)* | −0.11 |
| Married or de facto | 0.1 (−0.1; 0.3) | ||
| Education | 0.1 (−0.1; 0.3) | ||
| Being employed | 0.1 (−0.1; 0.3) | ||
|
| |||
| Type of treatment | |||
| Chemotherapy | −0.1 (−0.3; 0.1) | ||
| Radiation therapy | −0.2 (−0.4; 0.01) | ||
| Immunotherapy | 0.1 (−0.3; 0.4) | ||
| Hormone therapy | 0.1(−0.1; 0.3) | ||
| Time between diagnosis and baseline | 0.1(−0.02; 0.3) | ||
| History of cancer | −0.1 (−0.5; 0.2) | ||
| Presence of two or more comorbidities | −0.3 (−0.4; −0.1)* | ||
| BMI (kg/m2) | −0.1 (−0.1; −0.04)* | −0.05 (−0.06; −0.03)* | −0.25 |
|
| |||
| Self-efficacy | 0.2 (0.1; 0.3)* | 0.2 (0.08; 0.2)* | 0.17 |
| Social support | 0.2 (0.1; 0.3)* | 0.1 (0.05; 0.2)* | 0.13 |
| Outcome expectations | |||
| quartile 1 vs. 2 | 0.1 (−0.1; 0.3) | ||
| quartile 1 vs. 3 | −0.1 (−0.3; 0.2) | ||
| quartile 1 vs. 4 | 0.02 (−0.2; 0.3) | ||
|
| |||
| Urban area | 0.01 (−0.2; 0.2) | ||
β regression coefficients, CI confidence interval;
*p ≤ 0.05